hway in Chronic Lymphocytic Leukemia

Abstract

Download ultaneous targeting of the phosphoinositide 3-kinase (PI3K)/Akt pathway increases arsenic trioxide –dependent cytotoxicity of chronic lymphocytic leukemia (CLL) cells, whereas it has no significant (ATO) effects on normal lymphocytes. Combinations of ATO with small molecules that target PI3K and/or Akt may provide a novel approach for the treatment of CLL. Clin Cancer Res; 16(17); 4311–2. ©2010 AACR.

1 Figure or Table

Cite this paper

@inproceedings{Platanias2010hwayIC, title={hway in Chronic Lymphocytic Leukemia}, author={Leonidas C. Platanias}, year={2010} }